Skip to main content
OpenTrials

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,172 public trials 550 recruiting studies
Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients

NCT00089492

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Hobson City, Alabama, United States
  • Fountain Valley, California, United States
  • Los Angeles, California, United States
  • Los Angeles, California, United States
View all 27 locations
View Trial Details
Completed

A Study of Hepatitis C Virus (HCV) Polymerase Inhibitor Pro-Drug in Combination With PEGASYS With or Without COPEGUS in Patients With Chronic Hepatitis C (CHC) Genotype 1 Infection.

NCT00377182

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • La Jolla, California, United States
  • Long Beach, California, United States
  • Sacramento, California, United States
  • San Diego, California, United States
View all 18 locations
View Trial Details
Completed

A Study of RO5024048 in Combination With Ritonavir-Boosted Danoprevir With or Without Copegus (Ribavirin) in Interferon-Naïve Patients With Chronic Hepatitis C Genotype 1 (INFORM-SVR)

NCT01278134

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • La Jolla, California, United States
  • Sacramento, California, United States
  • Orlando, Florida, United States
  • Marietta, Georgia, United States
View all 32 locations
View Trial Details
Completed

A Study of RO5190591 (Danoprevir) in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1 Virus Infection

NCT00963885

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Phoenix, Arizona, United States
  • Long Beach, California, United States
  • Los Angeles, California, United States
  • Sacramento, California, United States
View all 43 locations
View Trial Details
Completed

ANNAPURNA: A Study of The Combination of RO5466731, RO5190591, Ritonavir and Copegus (Ribavirin) With or Without RO5024048 in Patients With Chronic Hepatitis C Who Are Either Treatment-Naïve or Have Previously Experienced a Null Response to Interferon-Based Treatment

NCT01628094

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • La Jolla, California, United States
  • Englewood, Colorado, United States
  • South Miami, Florida, United States
  • Marietta, Georgia, United States
View all 31 locations
View Trial Details

Related conditions